PATENT CLAIM ANALYSIS

Application Number: 15984993
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "158100"]

Abstract:
The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1β binding antibody or functional fragment thereof.

Claim (Index 16):
The method according to  claim 1 , wherein the subject has improved vascular structure and function after 3 months of treatment.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.16216
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14442536', '14347071', '15359784', '13955673', '14861191']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618734812278616
- 35 USC 102 Novelty (BERT): 0.5398932787123041
- Combined Prediction Score: 0.7396754609763059
- Mean Citation Score: 311.903526
- Max Citation Score: 380.54147
- Similarity Product: 376.7532292327565

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test